BioNTech SE

Public

Mainz, Rhineland-PalatinateHealthcarehttps://www.biontech.com/us/en/home.html

Last Round

Grant

May 20, 2025

Total Funding Raised

$1.87B

Company Overview

BioNTech SE is a biotechnology company that develops and commercializes immunotherapies for cancer and other infectious diseases.

Sector

Healthcare

AI Layer

Application

Keywords

mRNA vaccine platformmRNA cancer immunotherapiesCOVID-19 mRNA vaccineindividualized cancer immunotherapycancer and infectious disease immunotherapypharmaceutical co-development partnership modelengineered cell therapyCAR-T cell therapy developmentantibody-drug conjugates (ADCs)drug commercialization profit-sharinggovernment vaccine supply contractssmall molecule immunomodulators

BioNTech SE Comps

Public and private peers based on sector, stage, and business model.

BioNTech SE comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

BioNTech SE Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	May 20, 2025
Follow-on Offering	Jul 27, 2020
Debt	Jun 11, 2020
Debt	Dec 17, 2019
IPO Announced	Oct 10, 2019
Strategic	Aug 30, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

f k

CEO

Executive Team

Hesselaar Birgit

CEO

Executive Team

Ugur Sahin

Chief Executive Officer Co-Founder

Founding Team

Ramon Zapata

Chief Financial Officer

Executive Team

View all key people

BioNTech SE Investors

Notable investors and investment history

BioNTech SE investors
Investor	Rounds
Redmile Group	Series B, Series A
Janus Henderson Group	Series B, Series A
Temasek	Debt
MIG Capital	Seed
UK government	Grant
Bryan, Garnier & Co.	Follow-on Offering, IPO
Canaccord Genuity	Follow-on Offering, IPO

View all Investors

BioNTech SE Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

BioNTech SE Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersMainz, Rhineland-Palatinate

Employee Range5,198

Year Founded2008

Last FundingMay 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.